Jump Financial’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.15M | Buy |
31,673
+5,158
| +19% | +$188K | 0.01% | 908 |
|
|
2025
Q1 | $960K | Sell |
26,515
-86,301
| -76% | -$3.12M | 0.01% | 834 |
|
|
2024
Q4 | $4.75M | Buy |
112,816
+87,825
| +351% | +$3.69M | 0.1% | 271 |
|
|
2024
Q3 | $1.39M | Sell |
24,991
-2,298
| -8% | -$128K | 0.03% | 657 |
|
|
2024
Q2 | $1.12M | Buy |
+27,289
| New | +$1.12M | 0.02% | 764 |
|
|
2023
Q4 | – | Sell |
-23,436
| Closed | -$835K | – | 2151 |
|
|
2023
Q3 | $835K | Buy |
23,436
+6,295
| +37% | +$224K | 0.03% | 759 |
|
|
2023
Q2 | $791K | Buy |
17,141
+2,803
| +20% | +$129K | 0.03% | 811 |
|
|
2023
Q1 | $575K | Sell |
14,338
-40,968
| -74% | -$1.64M | 0.02% | 826 |
|
|
2022
Q4 | $2.56M | Buy |
55,306
+43,508
| +369% | +$2.02M | 0.13% | 199 |
|
|
2022
Q3 | $489K | Buy |
+11,798
| New | +$489K | 0.02% | 912 |
|